An unusual form of BRAF-V600E mutated hairy cell neoplasm with clinical resistance to BRAF inhibition: Challenging precision medicine.
Am J Hematol
; 99(3): 497-501, 2024 03.
Article
in En
| MEDLINE
| ID: mdl-38264797
ABSTRACT
Distinct outcomes of BRAF inhibition in BRAF-mutated hairy cell neoplasms with wild-type or mutant TP53, and alternative strategies to overcome mutant TP53.
Full text:
1
Database:
MEDLINE
Main subject:
Proto-Oncogene Proteins B-raf
/
Neoplasms
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Am J Hematol
Year:
2024
Type:
Article
Affiliation country:
Italy